Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome

Following treatment, two-thirds of the cohort exhibited a greater than 50 percent reduction in seizure frequency.

The post Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome appeared first on NORML.